Investments in the Future
Because of continued global investment in research and development Promega has extensive intellectual property with over 504 patents either issued or pending. In addition to developing our own intellectual property, Promega works with academic institutions and other entities to licenses and develop promising technologies.
Promega broke ground in 2011 for a current Good Manufacturing Practice (cGMP) facility dedicated to accommodate business growth and its customers who need FDA-regulated molecular biology products such as sample preparation systems and reagents that are part of diagnostic and medical tests sold by human diagnostic test providers.
This cGMP facility includes a number of environmentally sensitive construction practices such as geothermal heating and cooling, dark sky-compliant lighting, prairie restoration, bio retention ponds for storm water run off, electric vehicle charging stations and a living wall.